digital health companies glp-1 weight loss Why payers are hesitant to cover drugs for GLP-1 Business Report for Healthtech

The microdosing tirzepatide chart offers an alternative approach for researchers who find standard dosing too aggressive with any compound

60-70% regain sperm

Clinical data on semaglutide and tirzepatide shows average weight loss of 12 lbs/week during dose escalation, with steeper losses in months three through six as the dose reaches maintenance

If you anticipate schedule disruptions due to travel or life events, plan ahead by adjusting your injection day (maintaining at least 72 hours between doses) rather than missing doses entirely

According to new research, mitochondrial-derived peptides such as MOTS-c have a role in maintaining mitochondrial function and protecting cells under different stresses 1